Apart from the possibility that a single gene may be insufficient to determine HCC occurrence, another plausible explanation is that the loss of functional p53 is achieved by p53wt inactivation rather than TP53 mutation, suggesting the presence of potent p53 inhibitors during the progression from precancerous to cancerous stages in HCCs. The gene discussed is TP53; the disease is hepatocellular carcinoma.